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Abstract
Objective: Durable mechanical circulatory support is a proven therapy to extend
survival for patients with end-stage heart failure (HF). The International Society for
Heart and Lung Transplantation guidelines recommend a detailed psychosocial
assessment when selecting candidates for durable mechanical circulatory support.
Currently, there are no formally validated psychosocial evaluation tools for left
ventricular assist device (LVAD) candidacy. The Stanford Integrated Psychosocial
Assessment for Transplantation (SIPAT) uses a multidisciplinary algorithm to
evaluate the impact of pre-transplant risk factors on post-transplant outcomes.
Emerging literature suggests that the SIPAT might be useful for assessing
psychosocial risk factors for LVAD outcomes.
Methods: A total of 268 consecutive patients (median age 66 years, 84.6% male)
with terminal HF were evaluated before LVAD implantation with a SIPAT
assessment. Key outcomes included readmission and mortality rates at 30 days and
two years.
Results: After screening, 234 subjects met the inclusion criteria and were analyzed.
The Patient Readiness subscale of the SIPAT was statistically significant in
predicting two-year mortality (B = .167, P < .001; Nagelkerke r2 = .106). Scores on
the SIPAT did not correlate to 30-day readmission, 30-day mortality, or two-year
readmission rates.
Discussion: In this study, only the Patient Readiness score was associated with
mortality at two-years post-implantation. This research elucidates the potential
longer-term impact of psychosocial factors on LVAD outcomes and the SIPAT’s
utility in evaluating LVAD candidacy.
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Introduction
Approximately 6 million adults in the United States alone are diagnosed with heart
failure (HF).1 Of those, about half, or 3 million, are estimated to die within five years
of diagnosis.1 In addition to mortality, HF is estimated to cost the nation
approximately $30.7 billion each year in ongoing healthcare expenditures as well as
decreased productivity with missed days of work.1 For these reasons, a great deal
of innovation and effort is geared toward optimizing advanced therapies for HF.2
Despite guideline-directed medical therapy, a subset of heart failure (HF) patients
will decline and progress to end-stage HF. At this point, options to improve survival
include heart transplantation or implanting a durable mechanical circulatory support
device, such as a left ventricular assist device (LVAD). While heart transplantation
is viewed as the gold-standard intervention for end-stage HF, the limited availability
of donor hearts necessitates other interventions. It is estimated that annually 35,000
– 100,000 individuals with advanced HF in the United States could benefit from a
mechanical circulatory support device.3
LVADs are the most commonly used durable support device for HF; they unload the
left ventricle via mechanical pump support, which results in adequate systemic
circulation.4 When considering pre-surgical candidacy for transplant or an LVAD,
The International Society for Heart and Lung Transplantation (ISHLT) guidelines
recommend a detailed psychosocial evaluation as part of the multidisciplinary
evaluation process. This recommendation is based on the association of various
psychosocial risk factors to increased rates of hospital readmission, morbidity, and
mortality following surgical intervention in this population. Common psychosocial
factors considered in this process include adequacy of social support,
psychological/psychiatric stability, degree of patient knowledge and engagement in
their own care, treatment compliance, adaptation of key lifestyle factors, adequacy
of cognitive functioning, and history with substance use.4
Various validated psychosocial risk-factor assessment tools exist for the evaluation
of transplant candidacy.5,6 Although the importance of evaluating psychosocial risk
factors before heart transplantation has been established, there is limited literature
regarding how psychosocial risk factors predict clinical outcomes for patients
undergoing LVAD implantation.7-13 Due to the lack of validated LVAD assessment
tools, the same parameters used for transplant candidacy are used before LVAD
implantation. It is assumed that a strong psychosocial overlap exists; however, this
overlap does not account for differences in specific psychosocial issues or levels of
readiness that may have alternate implications for LVAD candidacy. For example,
care after an LVAD implantation requires a high level of patient engagement and
strong caregiver support for optimal outcomes. Providers need specific and
measurable behavioral and observational markers to assess the level of risk and
subsequent outcomes related to psychosocial risk factors.
The Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) is one
measure for transplant candidacy. The SIPAT is commonly used to evaluate
psychosocial risk factors associated with outcomes for heart transplantation but has
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not been validated to measure psychosocial candidacy for durable LVAD
implantation.
The current study aims to assess the SIPAT measure for use in LVAD candidacy
evaluation by (1) demonstrating the utility of SIPAT scores to predict outcomes in
those undergoing LVAD implantation and (2) demonstrating the utility of each
domain within the SIPAT to predict outcomes differentially. Domains include Patient
Readiness, Social Support, Psychological Stability, and Substance Use. Due to the
above-noted limitations in the current literature, analysis of the existing scores could
clarify the utility of the SIPAT in predicting clinical outcomes for those undergoing
LVAD implantation, with the advantage of analyzing these outcomes over a longer
period than previously studied (up to two years) and with a larger sample size.
Longer-term evaluation of outcomes related to psychosocial predictors is
considered important given the likelihood of delayed consequences due to these
factors. This data analysis also identifies the relative contribution of various
psychosocial domains to clinical outcomes. From a practical and clinical
perspective, enhanced clinical outcomes prediction could significantly reduce
readmission rates and mortality related to LVAD intervention.
The primary research questions include the following:
▪

How do the SIPAT total and subscale scores perform as predictors of clinical
outcomes (i.e., 30-day readmission and mortality rates, two-year
readmission and mortality rates) for patients undergoing LVAD implantation?

▪

What is the relative contribution of various demographic variables and
psychosocial domains of the SIPAT in predicting clinical outcomes (i.e., 30day readmission and mortality rates, two-year readmission and mortality
rates) for patients undergoing LVAD implantation?

Methods
This single-center, retrospective study included 268 consecutive adults (> 18 years
of age) who were evaluated for candidacy by a multidisciplinary team and underwent
durable LVAD implantation as a bridge to transplant or destination therapy between
2009 and 2017. To be included in the study, patients had documented pre-surgical
psychosocial evaluation for surgical candidacy utilizing the SIPAT OR sufficient
psychosocial documentation to allow for a retrospective calculation of a pre-surgical
SIPAT score. Patients were not excluded based on gender, sex, or racial or ethnic
origin. The local Institutional Review Board reviewed the study, and a waiver of
informed consent was granted. This study fully complies with the ISHLT Ethics
statement.

SIPAT
The SIPAT score consists of 21 items organized into four subscales measuring
patient readiness, social support, psychological stability, and substance use. A total
score is calculated and used to assess candidacy.5 The patient readiness subscale
assesses the understanding of the illness and intervention and the willingness and
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desire for the intervention. The social support subscale evaluates the availability and
ability of the patient’s support network to offer appropriate care and reinforce
recovery. The psychological stability subscale assesses the patient’s current and
historical psychological well-being. Finally, the substance use subscale assesses
the patient’s current and historical use of alcohol, nicotine, and illicit substances.
Trained research assistants, blinded to patient outcome data, retrospectively rated
patients on the SIPAT utilizing psychosocial evaluations and data documented in
the electronic medical record before implantation. The blinded lead investigator
independently confirmed these scores to ensure reliability and consistency.

Demographic and Outcome Variables
Information on study participants included a comprehensive set of structured data
elements from an integrated electronic medical record system and facility registries
for patients receiving advanced heart failure services. Data elements included age
at discharge, sex, race, ethnicity, primary language, marital status, employment
status, and type of insurance coverage.

Readmission and Mortality
The primary outcomes were 30-day and two-year post-discharge readmission rates
and mortality. Thirty-day mortality was defined as death occurring less than 30 days
after the date of hospital discharge for the LVAD implantation procedure; patients
who did not survive surgical implantation were excluded. Two-year mortality was
calculated when death occurred following discharge for LVAD surgical implantation;
of note, those who did not survive 30-days post-discharge were excluded from the
calculation. Thirty-day and two-year readmission rates were calculated based on
first readmissions during the specified time frame and excluded outpatient
procedures and scheduled diagnostic follow-ups in the hospital, such as heart
catheterization procedures.

Results
Of 268 total participants, 234 met inclusion and exclusion criteria. Thirty-four
participants were excluded due to incomplete historical medical records. Patient
demographics are shown in Table 1. The average age was 63.5±13.4 years, and
the majority were male, white, and spoke English as their primary language. Most
participants were retired or disabled and were covered by Medicare health insurance
plans, which is expected for this population.
Table 2 displays descriptive data for all participants and cohorts stratified by primary
outcomes, their SIPAT subscale, and total scores. Concerning mortality, 36
participants died within two years, although relatively few died during the index
LVAD hospitalization or within 30 days post-discharge. The mean number of days
between index discharge and death was 319 (median = 302).
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Table 1. Study Population Demographics. A total of 234 patients were included.
Characteristics
Age at Discharge (years)

N (Frequency)

Range
Mean (±SD)

20-87
63.5 (±13.4)

Male
Female

198 (84.6%)
36 (15.4%)

Asian
Black or African American
White
Other/Unknown

19 (8.1%)
21 (9.0%)
150 (64.1%)
44 (18.8%)

English
Other/Unknown

214 (91.5%)
20 (8.5%)

Employed
Retired
Disability
Active-Duty Military
Unemployed
Other/Unknown

23 (9.8%)
135 (57.7%)
57 (24.3%)
3 (1.3%)
13 (5.6%)
3 (1.3%)

Medicare/Supplements
Commercial/Private
MediCal/County Services
Other/Unknown

148 (63.2%)
74 (31.6%)
10 (4.3%)
2 (0.9%)

Sex
Race/Ethnicity

Primary Language

Employment Status

Type of Insurance

Over 90% of discharged participants received additional acute care services within
the two-year post-discharge period, although less than a quarter was readmitted
within 30 days. Among the 147 participants who were readmitted between 30 days
and two years, the mean number of days between index discharge and first
readmission date was 175 (median = 113). There was considerable variability in the
distribution of the SIPAT subscale and total scores among participants. However,
the mean total SIPAT score for all cohorts was within the thresholds considered for
“good” candidates (range = 7 to 20) or “minimally acceptable” candidates (range =
21 to 39) based on standards for organ transplantation.
Analyses examined the relative contributions of SIPAT total score, and subscales in
predicting primary outcomes. Binary logistic regressions were performed to
determine if SIPAT total scores predicted mortality or readmission. Variables were
assessed to ensure assumptions of the logistic regression were met. In particular,
the independent variables did not violate the multicollinearity assumption (VIF
range: 1.123 – 1.237). The linear relationship of log odds and independent variables
found that all independent variables met this assumption. However, the 30-day
mortality outcome exhibited a very low observed occurrence rate of 1.3% and was
excluded from additional analysis. This likely reflects how mortality was defined,
excluding patients who did not survive surgical implantation/index hospitalization.
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Patient Readiness
All Study Participants
234
(100%)

Social Support

Psychological Stability

Substance Use

SIPAT Total Score

Range

Mean

SD

Range

Mean

SD

Range

Mean

SD

Range

Mean

SD

Range

Mean

SD

0-18

5.6

4.0

0 - 19

3.3

3.5

0 - 18

6.2

4.3

0 - 23

4.3

4.2

3 - 64

19.3

10.8

No Documentation of Mortality within 2 Years
176
(75.2%)

0-16

5.1

3.6

0-14

2.9

3.0

0-17

5.9

4.0

0-23

4.1

4.3

3-57

17.8

9.5

0-15

6.6

4.1

0-15

4.8

4.4

0-14

6.4

4.8

0-9

4.0

2.9

8-47

21.8

9.5

Within 30 Days PostDischarge

19
(8.1%)
3
(1.3%)

0-9

5.0

4.6

1-3

2.0

1.0

0-5

1.7

2.9

0-1

0.7

0.6

3-13

9.3

5.5

Between 31 Days and 2
Years Post-Discharge

36
(15.4%)

1-18

7.8

4.8

0-19

4.6

4.9

0-18

7.7

5.3

0-18

6.1

4.4

3-64

26.2

14.5

Mortality within 2 Years
Died Before Discharge

58
(24.8%)
Readmission for Acute Care Services within 2 Years*
Total

Within 30 Days PostDischarge

48
(22.3%)

0-12

5.1

3.3

0-19

3.2

3.8

0-14

5.4

3.9

0-11

3.7

3.0

3-44

17.3

8.2

Between 31 Days and 2
Years Post-Discharge

147
(68.4%)

0-18

5.7

4.1

0-14

3.1

3.3

0-18

6.4

4.3

0-23

4.6

4.6

3-64

19.7

11.3

Total

195
(90.7%)
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Results from the binary logistic regression indicated that total SIPAT scores were
not statistically significant in predicting 30-day readmission, two-year readmission,
or two-year mortality.
Analyses using stepwise logistic regression models indicated that scores of the
individual SIPAT subscales (Patient Readiness, Social Support, Psychological
Stability, and Substance Use) did not predict 30-day or two-year readmission.
However, results from a model including all SIPAT subscales indicated that the
Patient Readiness subscale was statistically significant in predicting two-year
mortality (B = .167, P < .001; Nagelkerke r2 = .106). This study's SIPAT total scores
did not significantly predict 30-day readmission, two-year readmission, or two-year
mortality.
Figure 1 below compares the distributions of SIPAT subscale scores by participant
cohorts based on the occurrence of mortality within two years.

Figure 1. SIPAT Subscale Score Distributions. Cohorts are compared by twoyear mortality. Within each box plot, “X” denotes the mean score of the distribution.
Amount the SIPAT subscales, Pateient Readiness was a statistically significant
predictor of two-year mortality (B = .167, P < .001; Nagelkerke r2 = .106)

Discussion
This retrospective study evaluated the usefulness of the SIPAT psychosocial
assessment score as a predictor of outcomes among patients who underwent
durable LVAD implantation. Of the SIPAT’s subscales, the Patient Readiness
subscale was statistically significant in predicting survival after two years. In addition
to assessing the patient’s knowledge of heart failure causes and surgical
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procedures, the Patient Readiness subscale evaluates medical treatment
compliance and comprehension of patients’ current disposition and responsiveness
to medical intervention. These results have implications for optimizing patient
selection, reducing risk before surgery, optimizing compliance, and monitoring
psychosocial function, particularly during longer post-surgery periods. Analyses of
total SIPAT scores were not statistically significant for any outcome measures.
Study limitations include the extrapolation of a standardized measure originally
designed to assess heart transplantation in a population receiving durable LVAD
support. Other psychosocial or environmental factors the SIPAT does not evaluate
may be relevant in predicting outcomes for patients undergoing LVAD implantation.
The study retrospectively calculated pre-surgical SIPAT scores based on examining
medical records at a single center. As with any investigation that is not populationwide, there are limits to generalizing results beyond the patient, practitioner, and
setting characteristics within the regional integrated healthcare delivery system
where the study was conducted. Finally, these data suggest implications for
assessing general candidacy for LVAD implantation; however, this study specifically
focuses on assessing preoperative psychosocial risk for adverse outcomes in a
subset of candidates who were accepted for and underwent LVAD implantation. It
does not address the cohort of potential candidates who never underwent LVAD
implantation due to psychosocial or medical contraindications. The study contributes
to an existing body of research by having a substantially larger sample size while
evaluating readmission and mortality rates during a two-year post-discharge time
frame in addition to the standard 30-day metric.
Future directions include conducting a prospective study that assesses the impact
of the SIPAT and other psychosocial determinants of health on outcomes for LVAD
patients. The integration of variables such as stage of heart failure, co-morbidities,
and biomarkers could further refine predictive algorithms for post-surgical outcomes.
Although the study results emphasize the importance of patient readiness for LVAD
implantation outcomes, further research on interventions to improve patient
readiness and resilience and subsequently improve outcomes is needed.
Additionally, addressing the status and impact of cognitive functioning on outcome,
readiness, or on response to psychological intervention are important factors to
consider when addressing risk for poor outcomes.
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